RESEARCH-USE BIOSIMILAR ANTIBODY
Iladatuzumab
Antibody-drug conjugate · IgG1
Iladatuzumab (MCDS0593A) is a humanized IgG1 anti-human CD79B monoclonal antibody. Iladatuzumab can be used to synthesize antibody-drug conjugates (ADC) Iladatuzumab vedotin (DCDS0780A; HY-P99657), which has the potential for B-cell non-Hodgkin lymphoma (B-NHL) research.
TARGETCD79B
YAntibody-drug conjugate
CATALOGSC-BS-490
CATALOG NUMBERSC-BS-490
MOLECULAR WEIGHTApprox. 145.18 kDa
PRODUCT FORMATAntibody-drug conjugate
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Iladatuzumab (MCDS0593A) is a humanized IgG1 anti-human CD79B monoclonal antibody. Iladatuzumab can be used to synthesize antibody-drug conjugates (ADC) Iladatuzumab vedotin (DCDS0780A; HY-P99657), which has the potential for B-cell non-Hodgkin lymphoma (B-NHL) research.
Iladatuzumab is a recombinant research-use antibody directed against CD79B.